Jerusalem, 20 November, 2026 (TPS-IL) — Some 200 pediatricians have signed a petition calling on Israel to include the Bexsero vaccine in the national health basket, making it available to infants and toddlers against meningococcal B disease. This is the seventh consecutive year that the vaccine’s inclusion has been requested.
Bexsero, manufactured by GSK, is a multicomponent recombinant vaccine designed to protect against invasive disease caused by meningococcal group B bacteria, which can cause meningitis and other life-threatening infections.
The bacterium, sometimes called the “aggressive bacteria,” is carried in the nose and throat of approximately 10% of adults and 25% of children and teenagers.
The petition notes that families currently must pay for the vaccine, with partial subsidies depending on their health insurance coverage. Pediatricians warn that the cost creates a gap between medical recommendations and families’ ability to follow them, contributing to inequality in access to protection against a potentially devastating disease.



